Constipation Treatment Market Report 2026

Constipation Treatment Market Overview

• Constipation Treatment market size has reached to $12.71 billion in 2025 • Expected to grow to $18.72 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Gastrointestinal Disorders Fueling The Constipation Treatment Market • Market Trend: Innovative Non-Pharmacologic Advancements Driving Next-Generation Therapies In Chronic Gastrointestinal Care • North America was the largest region and fastest growing region.

What Is Covered Under Constipation Treatment Market?

Constipation treatment refers to the numerous methods and measures taken to alleviate and manage the ailment, which is characterized by irregular or difficult bowel motions and frequently hard or dry stools. It is used to examine the rectum and lower, or sigmoid, colon and to treat constipation. The main types of therapeutics for constipation treatment are laxatives, chloride channel activators, peripherally acting mu-opioid receptor antagonists, GC-C (guanylate cyclase-c) agonists, and others. Laxatives refer to a material that facilitates the release of intestinal feces in humans that are used in constipation treatment to improve stool size, frequency, and motility. These are used for chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC) diseases and are distributed by various channels including hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Constipation Treatment Market Growth Forecast?

The constipation treatment market size is expected to see strong growth in the next few years. It will grow to $18.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to rising chronic constipation cases, increasing opioid usage, growing awareness of gut health, expansion of specialty gastroenterology care, improved access to novel therapeutics. Major trends in the forecast period include rising use of prescription therapies for chronic constipation, growing adoption of probiotics and gut health products, shift toward targeted mechanism-based drugs, increased focus on opioid-induced constipation management, expansion of online pharmacy distribution.

Global Constipation Treatment Market Segmentation

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics 2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC) 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners 2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators 3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs 4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists 5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

What Is The Driver Of The Constipation Treatment Market?

The rising incidence of gastrointestinal disorders is expected to boost the growth of the constipation treatment market going forward. Gastrointestinal disorders, often referred to as digestive disorders, encompass a range of conditions that affect the digestive tract. Constipation is a common symptom of many gastrointestinal (GI) disorders. The increasing prevalence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), propels the constipation treatment market's growth as these conditions frequently coincide with constipation, fostering a heightened need for specific and effective treatments amid growing awareness. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, approximately 26,890 new cases of stomach cancer are anticipated in the U.S. in 2024, with 16,160 cases in men and 10,730 in women. It is also expected that this type of cancer will lead to about 10,880 deaths, comprising 6,490 men and 4,390 women. Therefore, the rising incidence of gastrointestinal disorders is driving the growth of the constipation treatment industry.

Key Players In The Global Constipation Treatment Market

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Global Constipation Treatment Market Trends and Insights

Major companies operating in the constipation treatment market are focusing on developing innovative solutions, such as drug-free mechanical stimulation capsules (vibrating capsules), to meet the rising demand for effective, side-effect-sparing therapies driven by an aging population, greater opioid use, and patient preference for non-pharmacologic options. A vibrating capsule is a swallowable, single-use oral device that contains a small vibration motor and battery encased in a medical-grade, excretable shell; it is designed to mechanically stimulate the colon at programmed times to induce peristalsis, offering predictable bowel movements without the systemic effects of laxatives or prescription prokinetics. For instance, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system cleared by the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system includes a reusable activation pod and a single-use capsule containing a coin-sized vibration motor, an electronic control card, and batteries, all enclosed in a two-piece shell. The pod programs the capsule, which then delivers a series of short vibration cycles, approximately 190 cycles per hour with timed bursts and rests, engineered to stimulate colonic contractions.

What Are Latest Mergers And Acquisitions In The Constipation Treatment Market?

In March 2023, Ipsen, a France-based pharma company acquired Albireo Pharma Inc. for an undisclosed amount. Through the acquisition of Albireo, Ipsen strengthens its portfolio in rare diseases. Albireo Pharma Inc. is a US-based biotech company developing drugs for the treatment of chronic constipation.

Regional Outlook

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Constipation Treatment Market?

The constipation treatment market consists of sales of polyethylene glycol, bisacodyl, tegaserod, lubiprostone, and senna. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Constipation Treatment Market Report 2026?

The constipation treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the constipation treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.